The latest report by IMARC Group, titled “Ablation Devices Market Report by Device Technology (Radiofrequency Devices, Laser/Light Ablation, Ultrasound Devices, Cryoablation Devices, and Others), Application (Cancer Treatment, Cardiovascular Disease Treatment, Ophthalmologic Treatment, Gynecological Treatment, Urological Treatment, Cosmetic Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2023-2028“, The global ablation devices market size reached US$ 5.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2028, exhibiting a growth rate (CAGR) of 11.5% during 2023-2028.
Factors Affecting the Growth of the Ablation Devices Industry:
- Growing Incidence of Chronic Diseases:
The rising prevalence of chronic diseases like cancer, cardiac arrhythmias, and atrial fibrillation represents the major factor stimulating the market growth. Ablation procedures are integral to treating these conditions by precisely removing or destroying abnormal tissues. With the global population aging and lifestyle factors contributing to the increase in chronic diseases, there has been a rise in demand for ablation devices. These devices offer a minimally invasive alternative to traditional surgical treatments, making them indispensable tools for healthcare professionals in addressing the healthcare challenges posed by the growing burden of chronic illnesses.
- Ongoing Advancements in Ablation Technologies:
Continuous advancements in ablation technologies are propelling the market growth. Innovations in techniques and devices, such as radiofrequency ablation, cryoablation, and microwave ablation, have made ablation procedures more precise, minimally invasive, and safe for patients. These advancements broaden the scope of applications for ablation devices, allowing healthcare providers to treat various medical conditions effectively. The evolution of ablation technologies attracts medical professionals looking for state-of-the-art tools to improve patient outcomes, fostering a competitive and innovative landscape within the ablation devices market.
- Escalating Demand for Minimally Invasive Procedures:
Ablation devices have a minimally invasive nature, which translates into reduced patient discomfort, shorter hospital stays, and faster recovery times. Patients and healthcare providers increasingly favor minimally invasive treatments over traditional surgeries whenever feasible. Ablation devices cater to this preference across multiple medical specialties, including oncology, cardiology, and gynecology. By offering less invasive alternatives, ablation devices enhance patient comfort and contribute to improved clinical outcomes and cost-effectiveness, driving their adoption and growth within the medical field. The shift toward minimally invasive procedures is reshaping healthcare practices, with ablation devices at the forefront of this transformation.
Competitive Landscape with Key Player:
- Abbott Laboratories
- AngioDynamics Inc.
- AtriCure Inc.
- Boston Scientific Corporation
- CONMED Corporation
- Elekta AB (publ)
- Johnson & Johnson
- Medtronic plc
- Olympus Corporation
- Smith & Nephew plc
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/ablation-devices-market/requestsample
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Device Technology:
- Radiofrequency Devices
- Laser/Light Ablation
- Ultrasound Devices
- Cryoablation Devices
- Others
Radiofrequency devices represented the leading segment due to their proven effectiveness in various medical applications, offering precise tissue ablation while minimizing damage to surrounding healthy tissue
Breakup by Application:
- Cancer Treatment
- Cardiovascular Disease Treatment
- Ophthalmologic Treatment
- Gynecological Treatment
- Urological Treatment
- Cosmetic Surgery
- Others
Cancer treatment represented the largest segment as it addresses the rising incidence of cancer worldwide, with ablation devices playing a pivotal role in minimally invasive tumor removal and ablation therapies.
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
Hospitals held the majority of the market share on account of their comprehensive healthcare facilities and the need for advanced ablation technologies to cater to a wide range of medical conditions, from cardiac arrhythmias to cancer treatments.
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America’s dominance in the ablation devices market is attributed to its advanced healthcare infrastructure, increasing prevalence of chronic diseases, and high adoption rates of innovative medical technologies.
Global Ablation Devices Market Trends:
The escalating incidence of chronic diseases, including cancer, cardiac arrhythmias, and atrial fibrillation, represents the primary factor driving the market growth. Ablation devices play a crucial role in treating these conditions by precisely removing or destroying abnormal tissues, making them essential in addressing the growing healthcare burden of chronic illnesses globally. Apart from this, continuous advancements in ablation technologies, such as radiofrequency and microwave ablation, that enhance the precision and safety of procedures, attracting healthcare professionals and expanding the scope of applications across various medical specialties, thus fueling market growth. Furthermore, the shift toward minimally invasive approaches is transforming healthcare practices has accelerated the adoption of ablation devices, thus supporting market growth.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163